DEA rescheduling to III enables cannabinoids for pharma applications BECAUSE THERE ARE 2 HANDS BEING PLAYED BY THE WHITE HOUSE!!! Pharma and Politics.
1) FDA/Dept of Human Health & Services: provided scientific and clinical data to the DEA. This has NOTHING to do with recreational use and EVERYTHING to do with pharmaceutical applications....scientific data and clinical data and this is why the NIH/Dept of Human Health and Services is funding the Libby Study at Keck School of Medicine at USC. Clinical trial materials provided by LABS, import into U.S. approved by DEA/Dept of Justice.
2) Biden and Harris are in a re-election year, Biden pardons for simple possesion and Harris with Fat Joe rapper talking about the social injustices against blacks and hispanics, 'absurd and patently unfair' commented by Harris and TELLING the DEA 'looking forward to their hard work'.
Now for those with a sweet tooth.....The Libby Study at Keck was started about 9 months or so ago..give or take a few months BUT the CEO of LABS indicated publicly MUCH EARLIER the following...'we have over 20 strong clinical trials, many in late stage'. Those specific clinical trials LABS is involved with their "large traditional global pharmaceutical partner" could have been started in California, Canada, Israel, Germany, South America, Australia.....a global pharma company has locations GLOBALLY and the ability to do clinical trials with cannabinoids as API's in ANY country where legal!!!!
Does everyone see the 2 plays at hand now? Pharmaceutical and Political.